FIELD: medicine.
SUBSTANCE: invention covers new compounds of formula (I) 
where: one of groups R6, R7 and R8 meets formula (II) 
and groups X, Y1-Y4, R1-R14 and n possess the values specified in the patent claim, and also their pharmaceutically acceptable salts. Compounds I show activating effect with respect to PPARδ and/or PPARαreceptors.
EFFECT: applicability of compounds for treatment and prevention of the diseases modulated by PPARδ and PPARα agonists.
22 cl, 8 dwg, 1 tbl, 21 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHENYL DERIVATIVES AS PPAR AGONISTS | 2004 |
|
RU2374230C2 |
| BENZANNEALED COMPOUNDS AS PPAR ACTIVATORS | 2004 |
|
RU2367654C2 |
| PYRAZOLYL INDOLYL DERIVATIVES AS PPAR ACTIVATORS | 2005 |
|
RU2375357C2 |
| THIAZOLE-SUBSTITUTED INDOLYL-DERIVATIVES AND APPLICATION THEIROF AS PPAR MODULATORS | 2004 |
|
RU2344135C2 |
| PYRAZOLE- AND PHENYL DERIVATIVES AS PPAR INHIBITORS | 2005 |
|
RU2384573C2 |
| INDOLE DERIVATIVES CONTAINING ACETYLENE GROUP AS PPAR ACTIVATORS | 2005 |
|
RU2387639C2 |
| PHENYL DERIVATIVES CONTAINING ACETYLENE GROUP | 2005 |
|
RU2384565C2 |
| 3-PYRIDINE CARBOXAMIDE AND 2-PYRAZINE CARBOXAMIDE DERIVATIVES AS HDL-CHOLESTEROL RAISING AGENTS | 2007 |
|
RU2454405C2 |
| PRODUCT COMPRISING AT LEAST ONE SUBSTANCE INHIBITING ACTIVITY OF NO-SYNTHASE IN COMBINATION WITH AT LEAST ONE SUBSTANCE INHIBITING ACTIVITY OF PHOSPHOLIPASE A | 2000 |
|
RU2256465C2 |
| PYRIDINE-3-CARBOXAMIDE DERIVATIVES AS CB1 INVERSE AGONISTS | 2006 |
|
RU2404164C2 |
